These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 24720409

  • 1. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
    Sakai Y, Otsuka T, Ohno D, Murasawa T, Sakai S, Tsuruoka S.
    Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL, Nitvarro JF, Marcen R, Aguilera A, Tato A, Ottuño J.
    Miner Electrolyte Metab; 1997 Nov; 23(1):19-24. PubMed ID: 9058365
    [Abstract] [Full Text] [Related]

  • 4. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 5. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 6. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.
    Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD.
    Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274
    [Abstract] [Full Text] [Related]

  • 7. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S, Ueki K, Tokumoto M, Suehiro T, Kimura H, Taniguchi M, Fujimi S, Kitazono T, Tsuruya K.
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [Abstract] [Full Text] [Related]

  • 8. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 9. Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.
    Shigematsu T, Fukagawa M, Yokoyama K, Akiba T, Fujii A, Shinoda A, Akizawa T.
    Nephrology (Carlton); 2020 Aug; 25(8):634-643. PubMed ID: 31765028
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC, Chen CA, Wang CT, Chen HC.
    Ren Fail; 2008 Aug; 30(10):943-51. PubMed ID: 19016144
    [Abstract] [Full Text] [Related]

  • 11. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
    Ando R, Naito S, Inagaki Y, Hata T, Ishida Y, Chida Y, Takayama M, Tachibana K, Ohtsuka M, Inoue A.
    Ther Apher Dial; 2005 Feb; 9(1):16-23. PubMed ID: 15828901
    [Abstract] [Full Text] [Related]

  • 12. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
    Izumi M, Shirai K, Ito K, Miyamoto T, Matsumoto A, Takenaka Y, Nakagawa K, Yamanashi T, Takamitsu Y, Nakanish T.
    Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
    [Abstract] [Full Text] [Related]

  • 13. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M, Frølich A, Haaber A, Tvedegaard E, Thode J.
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [Abstract] [Full Text] [Related]

  • 14. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial.
    Basile C, Libutti P, Di Turo AL, Vernaglione L, Casucci F, Losurdo N, Teutonico A, Lomonte C.
    Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E, Bernardini J, Holley J, Chen T, Piraino B.
    Adv Perit Dial; 1993 Jan; 9():280-3. PubMed ID: 8105943
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Calcium balance and intact PTH variations during haemodiafiltration.
    Argilés A, Mion CM.
    Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
    [Abstract] [Full Text] [Related]

  • 18. Effect of lower calcium dialysate on laboratory abnormalities in chronic kidney disease-associated mineral and bone disorder.
    Bansal A, Sandhu G, Chitale RA, Jones J, Meisels IS.
    Am J Ther; 2012 Nov; 19(6):429-31. PubMed ID: 22020086
    [Abstract] [Full Text] [Related]

  • 19. Different routes bridging calcium in Japanese hemodialysis patients.
    Hamano T, Fujii N, Ito T, Imai E.
    Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.